PT Prodia Diagnostic Line Tbk (IDX:PRDL)

Market Cap	212.28B
Revenue (ttm)	59.59B -46.7%
Net Income	2.84B -92.1%
EPS	2.32 -92.1%
Shares Out	1.22B
PE Ratio	74.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,941,800
Open	173.00
Previous Close	173.00
Day's Range	170.00 - 175.00
52-Week Range	162.00 - 530.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About IDX:PRDL

PT Prodia Diagnostic Line Tbk manufactures in vitro diagnostic medical devices in Indonesia. The company offers various products for clinical chemistry, hematology, immunoassay, biomolecular diagnostics, rapid diagnostic tests, and urinalysis. It also offers reagents, calibrators and controls, instruments, and kits. The company was formerly known as PT DiaLine Systems Indonesia and changed its name to PT Prodia Diagnostic Line Tbk in April 2011. PT Prodia Diagnostic Line Tbk was founded in 2010 and is based in Bekasi, Indonesia.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 63
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PRDL

Financial Performance

In 2025, IDX:PRDL's revenue was 74.37 billion, an increase of 26.79% compared to the previous year's 58.66 billion. Earnings were 16.99 billion, an increase of 69.93%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 9, 2026

Data Sources Report a data error